Sarilumab administration in patients with severe COVID‑19: A report of four cases and a literature review
Affiliations: Department of Biomedical and Biotechnological Sciences, University of Catania, I‑95124 Catania, Italy, Department of Clinical and Experimental Medicine, Unit of Infectious Diseases, University of Messina, I‑98122 Messina, Italy, Department of Clinical and Experimental Medicine, Unit of Infectious Diseases, ARNAS Garibaldi Hospital, University of Catania, I‑95122 Catania, Italy, Unit of Clinical Toxicology, Policlinico G. Rodolico, School of Medicine, University of Catania, I‑95123 Catania, Italy
- Published online on: April 19, 2022 https://doi.org/10.3892/wasj.2022.159
- Article Number: 24
Copyright: © Marino et al. This is an open access article distributed under the terms of Creative Commons Attribution License.